Mary Cushman

Mary Cushman

University of Vermont

H-index: 154

North America-United States

About Mary Cushman

Mary Cushman, With an exceptional h-index of 154 and a recent h-index of 99 (since 2020), a distinguished researcher at University of Vermont,

His recent articles reflect a diverse array of research interests and contributions to the field:

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions …

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Comparative discrimination of Life’s Simple 7 and Life’s Essential 8 to stratify cardiovascular risk: is the added complexity worth it?

Plasma Metabolites and Life’s Simple 7 in REGARDS

Heparin dose intensity and organ support-free days in patients hospitalized for COVID-19

Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors

Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

Mary Cushman Information

University

Position

___

Citations(all)

207851

Citations(since 2020)

78248

Cited By

151698

hIndex(all)

154

hIndex(since 2020)

99

i10Index(all)

719

i10Index(since 2020)

586

Email

University Profile Page

Google Scholar

Top articles of Mary Cushman

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions …

Chest

2024/4/1

Faraaz Shah
Faraaz Shah

H-Index: 10

Mary Cushman
Mary Cushman

H-Index: 92

Comparative discrimination of Life’s Simple 7 and Life’s Essential 8 to stratify cardiovascular risk: is the added complexity worth it?

Circulation

2023/10/13

Mary Cushman
Mary Cushman

H-Index: 92

Plasma Metabolites and Life’s Simple 7 in REGARDS

Stroke

2024/3/11

Heparin dose intensity and organ support-free days in patients hospitalized for COVID-19

JACC: Advances

2024/3/1

Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors

American Journal of Preventive Cardiology

2024/3/1

Nathan Kong
Nathan Kong

H-Index: 4

Mary Cushman
Mary Cushman

H-Index: 92

Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort

Diabetes care

2024/3/1

Debora Kamin Mukaz
Debora Kamin Mukaz

H-Index: 2

Mary Cushman
Mary Cushman

H-Index: 92

Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study

Nature Communications

2024/2/19

Hello and Goodbye Research and Practice in Thrombosis and Haemostasis

Research and Practice in Thrombosis and Haemostasis

2024/2/15

Mary Cushman
Mary Cushman

H-Index: 92

Hepatocyte growth factor and risk of incident stroke in Black and White Americans in REGARDS

Research and Practice in Thrombosis and Haemostasis

2024/2/8

Insu Koh
Insu Koh

H-Index: 11

Mary Cushman
Mary Cushman

H-Index: 92

Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The cardiovascular health study

Thrombosis Research

2024/2/4

Oscar Lopez
Oscar Lopez

H-Index: 9

Mary Cushman
Mary Cushman

H-Index: 92

Endothelial Dysfunction Biomarkers and Chronic Kidney Disease Incidence in the REGARDS Cohort

Kidney International Reports

2024/5/1

Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study

Journal of Thrombosis and Haemostasis

2024/2/1

Omega-3 Fatty Acids and Risk of Ischemic Stroke in REGARDS

Translational Stroke Research

2024/4/27

Serum zinc concentration and dietary zinc intake in relation to cognitive function: an analysis of the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort

European Journal of Nutrition

2024/1/31

Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies

Kidney Medicine

2024/4/26

Mary Cushman
Mary Cushman

H-Index: 92

When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

2024/1/23

Pro-Neurotensin/Neuromedin N and Risk of Incident Chronic Kidney Disease and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study

The Journal of Clinical Endocrinology & Metabolism

2021/9/1

Mary Cushman
Mary Cushman

H-Index: 92

See List of Professors in Mary Cushman University(University of Vermont)

Co-Authors

academic-engine